Lokaltherapie chronischer Wunden bei Patienten mit den ... - AWMF

S3-Leitlinie 091-001 „Lokaltherapie chronischer Wunden bei den Risiken CVI, PAVK und Diabetes mellitus“
78. Jeffcoate WJ, Price PE, Phillips CJ, Game FL, Mudge E, Davies S, et al. Randomised controlled
trial of the use of the three dressing preparations in the management of chronic ulceration of the
foot in diabetes. Health Technology Assessment. 2009;13(54):1-110.
79. Palfreyman S, Nelson EA, Michaels JA. Dressings for venous leg ulcers: systematic review and
meta-analysis. BMJ. 2007;335(7613):244.
80. Ormiston MC, Seymour MT, Venn GE, Cohen RI, Fox JA. Controlled trial of Iodosorb in chronic
venous ulcers. British Medical Journal Clinical Research Ed. 1985;291(6491):308-10.
81. Holloway GA, Jr., Johansen KH, Barnes RW, Pierce GE. Multicenter trial of cadexomer iodine
to treat venous stasis ulcer. West JMed. 1989;151(1):35-8.
82. Miller CN, Newall N, Kapp SE, Lewin G, Karimi L, Carville K, et al. A randomized-controlled trial
comparing cadexomer iodine and nanocrystalline silver on the healing of leg ulcers. Wound Repair
Regen. 2010;18(4):359-67.
83. Jeffcoate WJ, Price PE, Phillips CJ, Game FL, Mudge E, Davies S, et al. Randomised controlled
trial of the use of three dressing preparations in the management of chronic ulceration of the foot in
diabetes. Health Technology Assessment (Winchester, England). 2009;13(WinchesterEngland):1-iv.
84. Sibbald RG, Coutts P, Woo KY. Reduction of bacterial burden and pain in chronic wounds
using a new polyhexamethylene biguanide antimicrobial foam dressing-clinical trial results. Advances
in Skin & Wound Care. 2011;24(2):78-84.
85. Meaume S, Vallet D, Morere MN, Téot L. Evaluation of a silver-releasing hydroalginate
dressing in chronic wounds with signs of local infection. Journal of Wound Care. 2005;14(9):411-9.
86. Jorgensen B, Price P, Andersen KE, Gottrup F, Bech-Thomsen N, Scanlon E, et al. The silverreleasing
foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg
ulcers: a randomised, controlled trial. International Wound Journal. 2005;2(1):64-73.
87. Gottrup F, Jorgensen B, Karlsmark T, Sibbald RG, Rimdeika R, Harding K, et al. Reducing
wound pain in venous leg ulcers with Biatain Ibu: a randomized, controlled double-blind clinical
investigation on the performance and safety. Wound Repair & Regeneration. 2008;16(5):615-25.
88. Romanelli M, Dini V, Polignano R, Bonadeo P, Maggio G. Ibuprofen slow-release foam
dressing reduces wound pain in painful exuding wounds: preliminary findings from an international
real-life study. Journal of Dermatological Treatment. 2009;#20(1):19-26.
89. Kerihuel JC. Effect of activated charcoal dressings on healing outcomes of chronic wounds.
Journal of Wound Care. 2010;19(5):208.
90. Vin F, Teot L, Meaume S. The healing properties of Promogran in venous leg ulcers. J Wound
Care. 2002;11(9):335-41. Epub 2002/11/15.
91. Di Mauro C, Ossino AM, Trefiletti M, Polosa P, Beghe F. Lyophilized collagen in the treatment
of diabetic ulcers. Drugs ExpClinRes. 1991;17(7):371-3.
92. Schmutz JL, Meaume S, Fays S, Ourabah Z, Guillot B, Thirion V, et al. Evaluation of the nanooligosaccharide
factor lipido-colloid matrix in the local management of venous leg ulcers: results of a
randomised, controlled trial. International Wound Journal. 2008;5(2):172-82.
93. Hardikar JV, Reddy YC, Bung DD, Varma N, Shilotri PP, Prasad ED, et al. Efficacy of
recombinant human platelet-derived growth factor (rhPDGF) based gel in diabetic foot ulcers: a
randomized, multicenter, double-blind, placebo-controlled study in India. Wounds: A Compendium
of Clinical Research & Practice. 2005;17(6):141-52.
94. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant
human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic
ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care. 1998;21(5):822-
7.
95. Bhansali A, Venkatesh S, Dutta P, Dhillon MS, Das S, Agrawal A. Which is the better option:
recombinant human PDGF-BB 0.01% gel or standard wound care, in diabetic neuropathic large
plantar ulcers off-loaded by a customized contact cast? Diabetes Research and Clinical Practice.
2009;83(1):e13-6. Epub 2008/12/17.
96. Institute for Quality Efficiency in Health Care. Vakuumversiegelung von Wunden. Final report
NO4-03. 4/20062006.
Seite 258 von 279 aktueller Stand: 12.06.2012